A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms ARTSCANIII
- 14 Dec 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Jun 2019.
- 12 Sep 2018 Planned primary completion date changed from 1 Nov 2024 to 1 Sep 2018.
- 12 Sep 2018 Status changed from recruiting to active, no longer recruiting.